*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| C229 - Malignant neoplasm of liver, not specified as primary or secondary - as a primary diagnosis code | C229 - Malignant neoplasm of liver, not specified as primary or secondary - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 5.3 | |
| Readmission Rate (%) | 28.1 | |
| Unplanned Readmission Rate (%) | 20.19 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 437: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 406: PANCREAS, LIVER AND SHUNT PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | DRG 421: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 40,116 | ||||
| Total Hospitalizations with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 487 | ||||
| DRG Share of Total Hospitalizations | 0.12 | ||||
| % of Total ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary in DRG | 39.05 | ||||
| Avg LOS at DRG | 6.14 | ||||
| Avg LOS with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 5.38 | ||||
| Readmission Rate at DRG | 26.88 | ||||
| Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 24.93 | ||||
| Unplanned Readmission Rate at DRG | 18.3 | ||||
| Unplanned Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 19.16 | ||||
| Total Medicare payments at DRG | $472,915,537 | ||||
| Total Medicare payments with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $5,332,925 | ||||
| Total Medicare payment per Day at DRG | $1,921 | ||||
| Total Medicare payment per Day with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $2,035 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,789 | ||||
| Total Medicare payment per Hospitalization with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $10,951 | ||||
| Total Medicare Charges at DRG | $2,356,079,688 | ||||
| Total Medicare Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $24,060,264 | ||||
| Avg Charges at DRG | $58,732 | ||||
| Avg Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $49,405 | ||||
| Mortality Rate at DRG | 10.79 | ||||
| Mortality Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 16.22 | ||||
| SNF Discharge Rate at DRG | 10.16 | ||||
| SNF Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 10.06 | ||||
| Home Discharge Rate at DRG | 35.89 | ||||
| Home Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 29.77 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 405: PANCREAS, LIVER AND SHUNT PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 407: PANCREAS, LIVER AND SHUNT PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 420: HEPATOBILIARY DIAGNOSTIC PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 408: BILIARY TRACT PROCEDURE EXCEPT ONLY CHOLECYSTECTOMY WITH OR WITHOUT C.D.E. WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 12,032 | |||
| Total Hospitalizations with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 24 | |||
| DRG Share of Total Hospitalizations | 0.04 | |||
| % of Total ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary in DRG | 1.92 | |||
| Avg LOS at DRG | 12.83 | |||
| Avg LOS with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 9.83 | |||
| Readmission Rate at DRG | 32.87 | |||
| Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | |||
| Unplanned Readmission Rate at DRG | 17.21 | |||
| Unplanned Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | |||
| Total Medicare payments at DRG | $494,323,756 | |||
| Total Medicare payments with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $838,559 | |||
| Total Medicare payment per Day at DRG | $3,203 | |||
| Total Medicare payment per Day with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $3,553 | |||
| Total Medicare payment per Hospitalization at DRG | $41,084 | |||
| Total Medicare payment per Hospitalization with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $34,940 | |||
| Total Medicare Charges at DRG | $2,312,237,801 | |||
| Total Medicare Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $3,478,840 | |||
| Avg Charges at DRG | $192,174 | |||
| Avg Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $144,952 | |||
| Mortality Rate at DRG | 6.86 | |||
| Mortality Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | |||
| SNF Discharge Rate at DRG | 17.46 | |||
| SNF Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | |||
| Home Discharge Rate at DRG | 36.29 | |||
| Home Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 50.0 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 435: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 436: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 441: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 691 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary in DRG | 8.83 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 5.25 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 24.2 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 16.44 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $8,191,365 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $2,256 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $11,854 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $40,081,575 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $58,005 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 29.38 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 14.76 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 16.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 432: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 434,264 | ||||
| Total Hospitalizations with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 157 | ||||
| DRG Share of Total Hospitalizations | 1.32 | ||||
| % of Total ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary in DRG | 2.01 | ||||
| Avg LOS at DRG | 3.94 | ||||
| Avg LOS with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 4.13 | ||||
| Readmission Rate at DRG | 22.76 | ||||
| Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 23.4 | ||||
| Unplanned Readmission Rate at DRG | 16.46 | ||||
| Unplanned Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 19.15 | ||||
| Total Medicare payments at DRG | $2,472,138,198 | ||||
| Total Medicare payments with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $854,867 | ||||
| Total Medicare payment per Day at DRG | $1,444 | ||||
| Total Medicare payment per Day with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $1,319 | ||||
| Total Medicare payment per Hospitalization at DRG | $5,693 | ||||
| Total Medicare payment per Hospitalization with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $5,445 | ||||
| Total Medicare Charges at DRG | $12,478,361,060 | ||||
| Total Medicare Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $4,509,973 | ||||
| Avg Charges at DRG | $28,735 | ||||
| Avg Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $28,726 | ||||
| Mortality Rate at DRG | 0.91 | ||||
| Mortality Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | ||||
| SNF Discharge Rate at DRG | 22.02 | ||||
| SNF Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 19.75 | ||||
| Home Discharge Rate at DRG | 46.68 | ||||
| Home Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 42.68 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 433: CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | DRG 437: MALIGNANCY OF HEPATOBILIARY SYSTEM OR PANCREAS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,013,774 | ||||
| Total Hospitalizations with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 119 | ||||
| DRG Share of Total Hospitalizations | 3.08 | ||||
| % of Total ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary in DRG | 1.52 | ||||
| Avg LOS at DRG | 5.34 | ||||
| Avg LOS with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 5.31 | ||||
| Readmission Rate at DRG | 28.25 | ||||
| Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 36.79 | ||||
| Unplanned Readmission Rate at DRG | 21.93 | ||||
| Unplanned Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 24.53 | ||||
| Total Medicare payments at DRG | $9,469,067,156 | ||||
| Total Medicare payments with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $1,127,959 | ||||
| Total Medicare payment per Day at DRG | $1,751 | ||||
| Total Medicare payment per Day with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $1,785 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,340 | ||||
| Total Medicare payment per Hospitalization with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $9,479 | ||||
| Total Medicare Charges at DRG | $43,343,716,813 | ||||
| Total Medicare Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $5,360,677 | ||||
| Avg Charges at DRG | $42,755 | ||||
| Avg Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $45,048 | ||||
| Mortality Rate at DRG | 3.72 | ||||
| Mortality Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | ||||
| SNF Discharge Rate at DRG | 20.84 | ||||
| SNF Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 14.29 | ||||
| Home Discharge Rate at DRG | 37.68 | ||||
| Home Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 34.45 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 948: SIGNS AND SYMPTOMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 92 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary in DRG | 1.18 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 6.4 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 34.67 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 28.0 | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $816,288 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $1,386 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $8,873 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $4,458,033 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | $48,457 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | NA | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 17.39 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD C229 - Malignant neoplasm of liver, not specified as primary or secondary | 30.43 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| INTEGRIS BAPTIST MEDICAL CENTER | 3300 NW EXPRESSWAY ST | OKLAHOMA CITY | OK | 73112 | 57 |
| CHRISTIANA CARE WILMINGTON HOSPITAL | 501 W 14TH ST | WILMINGTON | DE | 19801 | 45 |
| ASCENSION VIA CHRISTI ST. FRANCIS | 929 N SAINT FRANCIS ST | WICHITA | KS | 67214 | 34 |